Dexcom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2012 financial results after market close on Wednesday, May 2, 2012. Management will hold a conference call to review the company's first quarter financial performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom, Inc. website at www.dexcom.com, under the investor relations, events and webcast section, and will be archived for future reference. To listen to the conference call, please dial (800) 447-0521 (US/Canada) or (847) 413-3238 (International) and use the confirmation number "31897098" approximately five minutes prior to the start time. About Dexcom, Inc. Dexcom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for ambulatory use by patients with diabetes and by healthcare providers in the hospital. Cautionary Statement Regarding Forward Looking Statements Dexcom is a medical device company with a limited operating history. Successful commercialization of the company’s products is subject to numerous risks and uncertainties, including a lack of acceptance in the marketplace by physicians and patients, the inability to manufacture products in commercial quantities at an acceptable cost, possible delays in the company’s development programs, the inability of patients to receive reimbursement from third-party payors and inadequate financial and other resources. Certain of these risks and uncertainties, in addition to other risks, are more fully described in the company’s annual report on Form 10-K for the period ended December 31, 2011, as filed with the Securities and Exchange Commission on February 23, 2012.